Comparative Efficacy of Different Antiviral Therapy Regimens in Covid-19

Abstract

The present study comparatively analyzed the efficacy of different antiviral therapy regimens used in the treatment of COVID-19 in clinical practice.

The aim of the study was to identify the most effective approaches based on the results of therapy of patients with a confirmed diagnosis of a new coronavirus infection.

Based on the collected clinical data, we evaluated the dynamics of symptoms, viral load, length of hospitalization, complication rates and mortality with different antiviral drugs, including remdesivir, favipiravir and combinations with immunomodulators.

The results obtained show that there are differences in therapeutic efficacy between the considered treatment regimens, which allows us to justify the preference for the use of some of them depending on the clinical situation.

The work has implications for improving therapeutic strategies and optimizing clinical protocols for the management of COVID-19 patients.